Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes

Catherine C. Coombs(Memorial Sloan Kettering Cancer Center), Ahmet Zehir(Memorial Sloan Kettering Cancer Center), Sean M. Devlin(Memorial Sloan Kettering Cancer Center), Ashwin Kishtagari(Memorial Sloan Kettering Cancer Center), Aijazuddin Syed(Memorial Sloan Kettering Cancer Center), Philip Jonsson(Memorial Sloan Kettering Cancer Center), David M. Hyman(Memorial Sloan Kettering Cancer Center), David B. Solit(Memorial Sloan Kettering Cancer Center), Mark E. Robson(Memorial Sloan Kettering Cancer Center), José Baselga(Memorial Sloan Kettering Cancer Center), Maria E. Arcila(Memorial Sloan Kettering Cancer Center), Marc Ladanyi(Memorial Sloan Kettering Cancer Center), Martin S. Tallman(Memorial Sloan Kettering Cancer Center), Ross L. Levine(Memorial Sloan Kettering Cancer Center), Michael F. Berger(Memorial Sloan Kettering Cancer Center)
Cell stem cell
August 10, 2017
Cited by 846Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis